Pacira BioSciences, Inc.PCRXNASDAQ

Revenue (LTM)

$726M

+3.6% YoY

Net Income (LTM)

$7M

+107.1% YoY

Free Cash Flow

$137M

Revenue CAGR (5Y)

+11.1%

—Marginsstable

FCF$0.1B

Now profitable

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Revenue	542	667↑23.1%	675↑1.2%	701↑3.9%	726↑3.6%
Gross Profit	401	468↑16.5%	490↑4.9%	531↑8.2%	519↓2.1%
Operating Income	90	60↓33.3%	88↑46.1%	-73↓183.7%	28↑138.3%
Net Income	42	16↓62.1%	42↑163.7%	-100↓337.3%	7↑107.1%
EBITDA	114	140↑23.2%	155↑10.1%	29↓81.2%	119↑309.1%
EPS Diluted	0.92	0.34↓63.0%	0.89↑161.8%	-2.15↓341.6%	0.16↑107.4%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Cash & Equivalents	586	104↓82.2%	153↑47.2%	277↑80.5%	159↓42.7%
Total Current Assets	866	498↓42.5%	510↑2.3%	745↑46.1%	548↓26.5%
Total Assets	2,075	1,681↓19.0%	1,574↓6.4%	1,554↓1.3%	1,265↓18.6%
Total Current Liabilities	521	148↓71.6%	97↓34.1%	310↑218.2%	121↓61.1%
Total Liabilities	1,345	906↓32.6%	704↓22.3%	775↑10.1%	572↓26.2%
Total Equity	730	775↑6.1%	870↑12.3%	778↓10.5%	693↓11.0%
Total Debt	1,129	763↓32.4%	586↓23.2%	639↑9.0%	454↓28.9%
Net Debt	543	659↑21.3%	433↓34.4%	362↓16.3%	296↓18.3%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Operating Cash Flow	126	145↑15.6%	155↑6.5%	189↑22.5%	152↓19.7%
Capital Expenditure	-46	-30↑34.4%	-15↑49.6%	-11↑29.8%	-15↓44.2%
Free Cash Flow	80	115↑44.3%	139↑21.1%	179↑28.1%	137↓23.5%
Stock-Based Comp	42	48↑13.8%	48↓0.4%	51↑6.8%	58↑12.4%
Net Change in Cash	486	-481↓199.1%	49↑110.2%	123↑151.2%	-118↓195.8%

Values in millions except EPS · Ratios shown as percentages · Click any metric to drill down

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance